Hypouricemic agents reduce indoxyl sulfate excretion by inhibiting the renal transporters OAT1/3 and ABCG2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypouricemic agents reduce indoxyl sulfate excretion by inhibiting the renal transporters OAT1/3 and ABCG2
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-31
DOI
10.1038/s41598-021-86662-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cellular and Molecular Mechanisms of Kidney Injury in 2,8-Dihydroxyadenine Nephropathy
- (2020) Barbara Mara Klinkhammer et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2020) Boris Bikbov et al. LANCET
- Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin
- (2020) Minna Lehtisalo et al. CTS-Clinical and Translational Science
- Serum indoxyl sulfate is associated with mortality in hospital-acquired acute kidney injury: a prospective cohort study
- (2019) Wenji Wang et al. BMC Nephrology
- Pharmacological evaluation of dotinurad, a selective urate reabsorption inhibitor
- (2019) Tetsuya Taniguchi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein
- (2019) Kenji Ikemura et al. Scientific Reports
- Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression
- (2018) T. Takada et al. Scientific Reports
- Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
- (2018) Kenjiro Kimura et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The flavonoid-rich fraction from rhizomes of Smilax glabra Roxb. ameliorates renal oxidative stress and inflammation in uric acid nephropathy rats through promoting uric acid excretion
- (2018) Siwei Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes
- (2017) Wei Wu et al. Scientific Reports
- Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients
- (2017) Sunny Eloot et al. PLoS One
- Age-associated differences in transporter gene expression in kidneys of male rats
- (2016) Yong-Ji Xu et al. Molecular Medicine Reports
- Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations
- (2016) Hiroshi Miyata et al. Frontiers in Pharmacology
- Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout
- (2014) Tatsuo Hosoya et al. Clinical and Experimental Nephrology
- Renal Uptake of Substrates for Organic Anion Transporters Oat1 and Oat3 and Organic Cation Transporters Oct1 and Oct2 is Altered in Rats with Adenine-Induced Chronic Renal Failure
- (2012) Hiroki Komazawa et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Changes in expression of renal Oat1, Oat3 and Mrp2 in cisplatin-induced acute renal failure after treatment of JBP485 in rats
- (2012) Tao Liu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Effects of Chronic Renal Failure on Kidney Drug Transporters and Cytochrome P450 in Rats
- (2011) J. Naud et al. DRUG METABOLISM AND DISPOSITION
- Untargeted Metabolomics Identifies Enterobiome Metabolites and Putative Uremic Toxins as Substrates of Organic Anion Transporter 1 (Oat1)
- (2011) William R. Wikoff et al. JOURNAL OF PROTEOME RESEARCH
- Decreased Kidney Function and Crystal Deposition in the Tubules After Kidney Transplant
- (2010) Piero Stratta et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?
- (2010) S. Lekawanvijit et al. EUROPEAN HEART JOURNAL
- Indoxyl Sulfate Inhibits Nitric Oxide Production and Cell Viability by Inducing Oxidative Stress in Vascular Endothelial Cells
- (2009) Zohra Tumur et al. AMERICAN JOURNAL OF NEPHROLOGY
- ROS and PDFG-β receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration
- (2009) Hidehisa Shimizu et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- The Uremic Toxin 3-Indoxyl Sulfate Is a Potent Endogenous Agonist for the Human Aryl Hydrocarbon Receptor
- (2009) Jennifer C. Schroeder et al. BIOCHEMISTRY
- Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients
- (2009) F. C. Barreto et al. Clinical Journal of the American Society of Nephrology
- Elevated Uric Acid Increases the Risk for Kidney Disease
- (2008) R. P. Obermayr et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now